Brexit

Author: Nimisha Kotecha  |  Mar 27, 2018

Science and Technology Committee (Commons) – Leaving the EU

Science and Technology Committee (Commons) – Leaving the EU Pharmacovigilance: As defined by the World Health Organization, PV is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. Further outlined in Section 1 below. Legal basis of the EU QPPV: As defined by EU Directive 2010/84/EU and Regulation 1235/20101 and outlined within Module 1 of Good Pharmacovigilance